Outsmarting trogocytosis to boost CAR NK/T cell therapy

Chimeric antigen receptor (CAR) NK and T cell therapy are promising immunotherapeutic approaches for the treatment of cancer. However, the efficacy of CAR NK/T cell therapy is often hindered by various factors, including the phenomenon of trogocytosis, which involves the bidirectional exchange of me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramezani, Faezeh, Panahi Meymandi, Ahmad Reza, Akbari, Behnia, Tamtaji, Omid Reza, Mirzaei, Hamed, Brown, Christine E., Mirzaei, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652537/
https://www.ncbi.nlm.nih.gov/pubmed/37974170
http://dx.doi.org/10.1186/s12943-023-01894-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652537/
https://www.ncbi.nlm.nih.gov/pubmed/37974170
http://dx.doi.org/10.1186/s12943-023-01894-9

Ejemplares similares